Passage Bio to Participate in Upcoming Investor ConferencesGlobe Newswire • 2 months agoPHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative...